You are here » Home » Companies » Company Overview » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: N.A. ISIN Code: INE312C01025
BSE LIVE 15:40 | 17 Aug 1.47 1.47
(%)
OPEN

1.47

HIGH

1.52

LOW

1.47

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 1.47
PREVIOUS CLOSE 0.00
VOLUME 620813
52-Week high 2.95
52-Week low 1.40
P/E 11.31
Mkt Cap.(Rs cr) 115
Buy Price 1.47
Buy Qty 76242.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1.47
CLOSE 0.00
VOLUME 620813
52-Week high 2.95
52-Week low 1.40
P/E 11.31
Mkt Cap.(Rs cr) 115
Buy Price 1.47
Buy Qty 76242.00
Sell Price 0.00
Sell Qty 0.00

Syncom Formulations (India) Ltd. (SYNCOMFORMUL) - Company Information

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988, Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda. In addition to pharmaceutical formulations ...> More

COMPANY INFORMATION
Chairman : Kedarmal Bankda
Managing Director : Vijay Bankda
Independent Director : Vinod Kumar Kabra
Independent Director : Krishna Das Neema
Independent Director : Praveen Jindal
Director : Rinki Bankda
Company Secretary : Prachi Rathore
AUDITOR : S P Moondra & Co
IND NAME : Pharmaceuticals - Indian - Formulations
HOUSE NAME : Indian Private
Registered office
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093
Ph : 91-22-30887744
WEBSITE : http://www.sfil.in
E-mail : info@sfil.in